News und Analysen
EQS-News: ENCAVIS AG reaches ready-to-build (RTB) status for a 105 MW solar park in Mecklenburg-Western Pomerania
EQS-News: ENCAVIS AG reaches ready-to-build (RTB) status for a 105 MW solar park in Mecklenburg-Western Pomerania
EQS-News: SHOP APOTHEKE EUROPE 2022: RECORD SALES OF EUR 1.2 BILLION AND SIGNIFICANTLY IMPROVED MARGINS IN THE SECOND HALF OF THE YEAR.
EQS-News: SHOP APOTHEKE EUROPE 2022: RECORD SALES OF EUR 1.2 BILLION AND SIGNIFICANTLY IMPROVED MARGINS IN THE SECOND HALF OF THE YEAR.
![Acadia Healthcare Breaks Ground on New Behavioral Health Hospital in Arizona: https://mms.businesswire.com/media/20230306005668/en/1731758/5/ACHCAgave_BH_Groundbreaking_3.6.2023.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXp4V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--db9e2b0cb4632df04940bb8556eadeaf85fd7080/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ACHCAgave_BH_Groundbreaking_362023.jpg?locale=de)
Acadia Healthcare Breaks Ground on New Behavioral Health Hospital in Arizona
Acadia Healthcare Company today held a groundbreaking ceremony marking the beginning of construction on the new hospital that the company is building to serve residents of Mesa, Arizona, and
EQS-News: CEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE.
EQS-News: CEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE.
EQS-Adhoc: SHOP APOTHEKE EUROPE N.V.: No prolongation of his term as CEO by Stefan Feltens
EQS-Adhoc: SHOP APOTHEKE EUROPE N.V.: No prolongation of his term as CEO by Stefan Feltens
![Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN042Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ae05d9a008178586e36a804ddc8db7301200475e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/5009664_Horizon_Logo_Full-Color_CMYK_M01_-281-29.jpg?locale=de)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
![Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN042Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ae05d9a008178586e36a804ddc8db7301200475e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/5009664_Horizon_Logo_Full-Color_CMYK_M01_-281-29.jpg?locale=de)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Aurubis AG: Aurubis links factoring to sustainability criteria
EQS-News: Aurubis AG: Aurubis links factoring to sustainability criteria
EQS-News: Schaeffler AG: Acquisition of ECO-Adapt SAS strengthens Schaeffler’s portfolio of Lifetime Solutions
EQS-News: Schaeffler AG: Acquisition of ECO-Adapt SAS strengthens Schaeffler’s portfolio of Lifetime Solutions
![EQS-News: Nagarro estimates 2022 revenue grew 48.0% over 2021 in constant currency, reiterates 2023 guidance: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHRHV0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a51dfffa3501bb47508c09ae4205642a9674477b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Nagarro_Horizontal_Light_400x100px_300dpi.png?locale=de)
EQS-News: Nagarro estimates 2022 revenue grew 48.0% over 2021 in constant currency, reiterates 2023 guidance
EQS-News: Nagarro estimates 2022 revenue grew 48.0% over 2021 in constant currency, reiterates 2023 guidance
![EQS-News: Nagarro estimates 2022 revenue grew 48.0% over 2021 in constant currency, reiterates 2023 guidance: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHRHV0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a51dfffa3501bb47508c09ae4205642a9674477b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Nagarro_Horizontal_Light_400x100px_300dpi.png?locale=de)
EQS-News: Nagarro estimates 2022 revenue grew 48.0% over 2021 in constant currency, reiterates 2023 guidance
EQS-News: Nagarro estimates 2022 revenue grew 48.0% over 2021 in constant currency, reiterates 2023 guidance
![EQS-News: GRENKE invests in expanding digitalisation, presents preliminary results for 2022 financial year and publishes outlook for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBPdz09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--4db50f106cec03dc81a4271045bbc188ee53d7db/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Grenke_Logo.jpg?locale=de)
EQS-News: GRENKE invests in expanding digitalisation, presents preliminary results for 2022 financial year and publishes outlook for 2023
EQS-News: GRENKE invests in expanding digitalisation, presents preliminary results for 2022 financial year and publishes outlook for 2023
![EQS-Adhoc: GRENKE invests in expanding digitalisation, presents preliminary results for 2022 financial year and publishes outlook for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBPdz09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--4db50f106cec03dc81a4271045bbc188ee53d7db/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Grenke_Logo.jpg?locale=de)
EQS-Adhoc: GRENKE invests in expanding digitalisation, presents preliminary results for 2022 financial year and publishes outlook for 2023
EQS-Adhoc: GRENKE invests in expanding digitalisation, presents preliminary results for 2022 financial year and publishes outlook for 2023
![Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN042Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ae05d9a008178586e36a804ddc8db7301200475e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/5009664_Horizon_Logo_Full-Color_CMYK_M01_-281-29.jpg?locale=de)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs
EQS-News: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs
EQS-News: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs
EQS-News: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs
EQS-Adhoc: Ad hoc: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs and Reduces Workforce at its Germany Headquarters
EQS-Adhoc: Ad hoc: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs and Reduces Workforce at its Germany Headquarters
EQS-Adhoc: Ad hoc: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs and Reduces Workforce at its Germany Headquarters
EQS-Adhoc: Ad hoc: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs and Reduces Workforce at its Germany Headquarters
EQS-News: KION Group Achieves High Order Intake and Increase in Revenue in 2022, Significant Decline in Earnings
EQS-News: KION Group Achieves High Order Intake and Increase in Revenue in 2022, Significant Decline in Earnings
![EQS-News: Nagarro SE expands footprint and SAP capabilities with acquisition of MBIS: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHRHV0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a51dfffa3501bb47508c09ae4205642a9674477b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Nagarro_Horizontal_Light_400x100px_300dpi.png?locale=de)
EQS-News: Nagarro SE expands footprint and SAP capabilities with acquisition of MBIS
EQS-News: Nagarro SE expands footprint and SAP capabilities with acquisition of MBIS
![EQS-News: Nagarro SE expands footprint and SAP capabilities with acquisition of MBIS: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHRHV0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a51dfffa3501bb47508c09ae4205642a9674477b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Nagarro_Horizontal_Light_400x100px_300dpi.png?locale=de)
EQS-News: Nagarro SE expands footprint and SAP capabilities with acquisition of MBIS
EQS-News: Nagarro SE expands footprint and SAP capabilities with acquisition of MBIS
EQS-News: United Internet acquires 13.9 million treasury shares during its public share buyback offer
EQS-News: United Internet acquires 13.9 million treasury shares during its public share buyback offer
EQS-News: United Internet acquires 13.9 million treasury shares during its public share buyback offer
EQS-News: United Internet acquires 13.9 million treasury shares during its public share buyback offer
![Athleta Partners with 11 Elite Athletes to Continue its Mission of Empowering Women and Girls: https://mms.businesswire.com/media/20230301005144/en/1725841/5/Power_of_She_Collective_Photo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOHZxV1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7ed1bf83da98f0f8fe1e7060ca4b7b54f26220fc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Power_of_She_Collective_Photo.jpg?locale=de)
Athleta Partners with 11 Elite Athletes to Continue its Mission of Empowering Women and Girls
Today, in honor of Women's History Month and the upcoming International Women's Day, Athleta announced a new, dynamic community of inspirational brand partners who are both accomplished athletes
![Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN042Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ae05d9a008178586e36a804ddc8db7301200475e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/5009664_Horizon_Logo_Full-Color_CMYK_M01_-281-29.jpg?locale=de)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc